However, EPAS1 has also been described as tumor suppressive in various other cancer types including neuroblastoma, colon cancer, and hepatocellular carcinoma, and shown to reduce tumor growth and improve patient outcomes when overexpressed [45,46,47,48]. Here, EPAS1 is linked to hepatocellular carcinoma.